Steven Jungles

2021

In 2021, Steven Jungles earned a total compensation of $1.2M as Former Senior Vice President and Chief Technical Operations Officer at Inozyme Pharma.

Compensation breakdown

Non-Equity Incentive Plan$135,235
Option Awards$622,572
Salary$395,818
Total$1,153,625

Jungles received $622.6K in option awards, accounting for 54% of the total pay in 2021.

Jungles also received $135.2K in non-equity incentive plan and $395.8K in salary.

Rankings

In 2021, Steven Jungles' compensation ranked 8,282nd out of 12,415 executives tracked by ExecPay. In other words, Jungles earned more than 33.3% of executives.

ClassificationRankingPercentile
All
8,282
out of 12,415
33rd
Division
Manufacturing
3,667
out of 5,505
33rd
Major group
Chemicals And Allied Products
1,630
out of 2,375
31st
Industry group
Drugs
1,450
out of 2,096
31st
Industry
Pharmaceutical Preparations
1,078
out of 1,546
30th
Source: SEC filing on April 27, 2022.

Jungles' colleagues

We found three more compensation records of executives who worked with Steven Jungles at Inozyme Pharma in 2021.

2021

Axel Bolte

Inozyme Pharma

Chief Executive Officer

2021

Deborah Wenkert

Inozyme Pharma

Chief Medical Officer

2021

Henric Bjarke

Inozyme Pharma

Chief Operating Officer

News

In-depth

You may also like